Menu
Back to Journals » OncoTargets and Therapy » Volume 13
Original Research
The CXCR4 Antagonist, AMD3100, Reverses Mesenchymal Stem Cell-Mediated Drug Resistance in Relapsed/Refractory Acute Lymphoblastic Leukemia
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,744 | Dovepress* | 5,133+ | 864 | 5,997 | |
| PubMed Central* | 611 | 150 | 761 | ||
| Totals | 5,744 | 1,014 | 6,758 | ||
| *Since 6 July 2020 | |||||
View citations on PubMed Central and Google Scholar